Key result
GTS-21 alleviates acute lung injury by reducing ACE/ACE2 ratio and glycocalyx shedding via ADAM-17 inhibition.
Why the study?
GTS-21 is promising for treating LPS-induced acute lung injury, but the precise underlying mechanism remains unknown.
Population
Mouse models of ALI and AT2s injury
Comparison
GTS-21 vs LPS alone, with or without recombinant ADAM-17 or siRNA ADAM-17
Design
In vivo and in vitro preclinical study
Authors
Loading...
Hypothesis-generating in animal ALI models; leaves open translation to human acute lung injury.
GTS-21 demonstrates protective effects against LPS-induced acute lung injury in preclinical models by modulating macrophage polarization and reducing the ACE/ACE2 ratio and glycocalyx shedding.
Zhu et al. (2024) studied Acute lung injury (ALI). GTS-21 vs. LPS group was evaluated on Pathological alterations, lung permeability, inflammatory response, ACE/ACE2 ratio, and glycocalyx shedding. GTS-21 alleviated LPS-induced acute lung injury by attenuating the ACE/ACE2 ratio and glycocalyx shedding through the inhibition of macrophage M1 polarization-derived ADAM-17.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: